Global Clinical Laboratory Tests Market

Clinical Laboratory Tests Market Size, Share, Growth Analysis, By Type(Complete Blood Count, Basic Metabolic Panel Testing, HGB/ HCT testing, Comprehensive Metabolic Panel Testing), By End Use(Central Laboratories (Complete Blood Count, HGB/ HCT testing, Basic Metabolic Panel Testing, BUN Creatinine Testing), By Region - Industry Forecast 2024-2031

Report ID: SQMIG35I2276 | Region: Global | Published Date: February, 2024
Pages: 157 | Tables: 96 | Figures: 75

Clinical Laboratory Tests Market Competitive Landscape

The major players in the clinical laboratory test industry are continually working to improve patient outcomes and the effectiveness and effectiveness of healthcare by introducing new technologies and altering those that already exist. For instance, Omega Laboratories will begin conducting urine tests as part of its new Urine Drugs of Use Testing Services in December 2022, complementing its DNA testing in Canada.

Clinical Laboratory Tests Market Top Player’s Company Profiles

  • Quest Diagnostics Incorporated
  • Laboratory Corporation of America Holdings (LabCorp)
  • Siemens Healthineers AG
  • Roche Diagnostics
  • Abbott Laboratories
  • Thermo Fisher Scientific Inc.
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • Sysmex Corporation
  • Becton, Dickinson and Company (BD)
  • bioMérieux SA
  • Agilent Technologies, Inc.
  • Genomic Health, Inc.
  • Myriad Genetics, Inc.
  • Cepheid (a subsidiary of Danaher Corporation)
  • QIAGEN N.V.
  • Hologic, Inc.
  • Ortho Clinical Diagnostics
  • PerkinElmer, Inc.
  • GenMark Diagnostics, Inc.

Clinical Laboratory Tests Market

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Clinical Laboratory Tests Market size was valued at USD 103.67 Billion in 2022 and is poised to grow from USD 113.41 billion in 2023 to USD 232.70 billion by 2031, growing at a CAGR of 9.4% during the forecast period (2024-2031).

The major players in the clinical laboratory test industry are continually working to improve patient outcomes and the effectiveness and effectiveness of healthcare by introducing new technologies and altering those that already exist. For instance, Omega Laboratories will begin conducting urine tests as part of its new Urine Drugs of Use Testing Services in December 2022, complementing its DNA testing in Canada. 'Quest Diagnostics Incorporated', 'Laboratory Corporation of America Holdings (LabCorp)', 'Siemens Healthineers AG', 'Roche Diagnostics', 'Abbott Laboratories', 'Thermo Fisher Scientific Inc.', 'Bio-Rad Laboratories, Inc.', 'Danaher Corporation', 'Sysmex Corporation', 'Becton, Dickinson and Company (BD)', 'bioMérieux SA', 'Agilent Technologies, Inc.', 'Genomic Health, Inc.', 'Myriad Genetics, Inc.', 'Cepheid (a subsidiary of Danaher Corporation)', 'QIAGEN N.V.', 'Hologic, Inc.', 'Ortho Clinical Diagnostics', 'PerkinElmer, Inc.', 'GenMark Diagnostics, Inc.'

The growing prevalence of chronic diseases and infectious diseases worldwide is driving the demand for clinical laboratory tests. These tests play a crucial role in disease diagnosis, monitoring, and treatment.

Increasing Demand for Molecular Diagnostics: There is a growing demand for molecular diagnostic tests that can detect genetic variations, infectious diseases, and other biomarkers at the molecular level. Advances in genomics and targeted therapies have led to the integration of molecular diagnostics into routine clinical practice.

North America dominated the market in terms of share in 2022, and it is anticipated that it will continue to do so during the forecast period. This might be linked to the region's growing senior population, increased chronic illness prevalence, including cancer, and strong market penetration of cutting-edge diagnostic techniques. One of the primary cause’s deaths in North America, reported to the American Cancer Society as a whole, is cancer. Prostate cancer in males and cancer of the breast in women are the two cancers that are most frequently diagnosed. The regional market is anticipated to be driven by factors like rising patient awareness and growing inclination for novel techniques.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

Click here right-arrow
logo-images

Related Reports

Blood Testing Market
Buy Now GET FREE SAMPLE
Drug Testing Market
Buy Now GET FREE SAMPLE
Clinical Chemistry Analyzers Market
Buy Now GET FREE SAMPLE
Rapid Microbiology Testing Market
Buy Now GET FREE SAMPLE
Bioanalytical Testing Services Market
Buy Now GET FREE SAMPLE
Urinalysis Test Market
Buy Now GET FREE SAMPLE
Biological Safety Testing Market
Buy Now GET FREE SAMPLE
Veterinary Reference Laboratory Market
Buy Now GET FREE SAMPLE

Feedback From Our Clients

Global Clinical Laboratory Tests Market

Report ID: SQMIG35I2276

$5,300
BUY NOW GET FREE SAMPLE